Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020473 (
hyperlipidemia
)
15,891
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Lipemic serum from three patients with
acute pancreatitis
and type IV
hyperlipemia
was fractionated into very-low-density lipoproteins and clear serum. Amylase activity (determined by the Phadebas method) in the component fractions did not exceed that in the original lipemic serum. Addition of these fractions or VLDL and chylomicrons from asymptomatic patients with
hyperlipemia
to nonlipemic serum from patients with "routine acute pancreatitis" did not inhibit amylase activity or alter the electrophoretic mobility of amylase isoenzymes. Therefore the normal amylase activity often observed in hyperlipemic pancreatitis does not result from an inhibition of amylase activity by serum lipoproteins.
...
PMID:Possible mechanisms of normal amylase activity in hyperlipemic pancreatitis. 20 33
A case of diabetic
lipemia
is reported in a 27 year-old man admitted for
acute pancreatitis
. Initial investigations revealed gross hyperlipoproteinemia and ketoacidosis. Hyperlipoproteinemia was progressively corrected up to normalization in four weeks under insulin-therapy; the metabolic control of diabetes was obtained in parellel. This feature is caracteristic of "diabetic lipemia". The following sequence could be suggested: onset of diabetes, occurence of diabetic
lipemia
and then
acute pancreatitis
.
...
PMID:[Acute pancreatitis during "diabetic lipemia": unusual disclosure of insulin-dependent diabetes (author's transl)]. 22 21
Although it is widely known that patients with severe
hyperlipemia
may have pancreatitis, it is not generally appreciated that such patients may have recurrent abdominal pain of variable character and intensity not due to pancreatitis. Review of 35 patients followed in our clinic for 1--11 years showed that 54% had recurrent abdominal pain, while only 29% had pancreatitis. Although mild pain occurred frequently with plasma triglycerides in the 2000--5000 mg/dl range, triglycerides over 6000 mg/dl were often associated with severe pain and physical findings which necessitated hospitalization, often led to the misdiagnosis of pancreatitis and other intra-abdominal catastrophes and resulted in multiple unnecessary diagnostic studies and operations. When recognized, the pain subsided within 48 hours upon cessation of oral intake and treatment with intravenous electrolyte solutions. Furthermore, effective treatment of the
hyperlipemia
prevented both the attacks of severe pain and the pancreatitis which otherwise occurred (or recurred) in a significant fraction of the patients. These data confirm the existence of hyperlipemic abdominal crisis as a distinct entity and testify to the importance of recognizing this syndrome in order to avoid the occurrence of
acute pancreatitis
and the performance of unnecessary and potentially harmful surgery.
...
PMID:The natural history and surgical significance of hyperlipemic abdominal crisis. 48 15
This case focuses on the biochemical findings in
acute pancreatitis
and the role of the laboratory in the diagnosis and management of such patients. It also illustrates a major unappreciated problem in the use of amylase determinations in patients with
acute pancreatitis
: normal serum amylase activity in the presence of
hyperlipemia
.
...
PMID:(Washington University case conference): acute pancreatitis, hyperlipemia, and normal amylase. 64 16
Severe pancreatic exocrine insufficiency was demonstrated in a 41 year old man with familial type I hyperlipoproteinemia (fat-induced
hyperlipemia
). Plasma triglyceride concentration failed to increase significantly with increased dietary fat intake, and fecal fat excretion was markedly increased. Indices of intestinal function were normal. Pancreatic enzyme therapy resulted in reduced fat excretion and increased plasma triglyceride concentration. Secretin stimulation tests revealed impaired duodenal fluid volume, bicarbonate and pancreatic enzyme responses. Insulin-dependent diabetes mellitus had been diagnosed three years earlier. No attacks of
acute pancreatitis
had occurred in the preceding 20 years, and it is suggested that pancreatic damage may have resulted from repeated subclinical pancreatic insults due to elevated plasma lipid levels. This report is the first to indicate that pancreatic exocrine insufficiency may occur as a late complication of hyperlipemic disorders in the absence of recurrent
acute pancreatitis
. Steatorrhea may not be apparent because of therapeutic restriction of dietary fat, and the first manifestation of pancreatic exocrine disease may be an amelioration of fat-induced
hyperlipemia
.
...
PMID:Subclinical chronic pancreatitis in type I hyperlipoproteinemia. 83 83
The operative discovery of
acute pancreatitis
associated with gross
hyperlipidaemia
but a normal or high elevated serum amylase concentration has been described. We report a case of
acute pancreatitis
in which serial dilutions of serum resulted in a 338% rise in the serum amylase concentrations. The importance of appreciating this effect of
hyperlipidaemia
on the serum level measurements in patients with
acute pancreatitis
is re-emphasised.
...
PMID:A cause of misleading serum amylase concentrations in acute pancreatitis. 87 Sep 64
A patient is described with
acute pancreatitis
which was probably caused by furosemide. Administration of furosemide on two separate occasions was associated with increases in serum amylase concentrations and recurrence of abdominal pain. This case is of further interest because of the presence of
hyperlipemia
in the absence of an underlying lipid abnormality. Following recovery from pancreatitis, the lipoprotein pattern evolved from type V to type III, type IIA, and finally to normal.
...
PMID:Acute pancreatitis secondary to furosemide with associated hyperlipidemia. 90 Jan 1
Twelve patients with prior episodes of alcoholic pancreatitis and
hyperlipemia
were admitted to a metabolic ward during a quiescent period. By lipid feeding (316 to 894 Gm. per day), significant hypertriglyceridemia (greater than 600 mg. per 100 ml.) was induced in 11 of the 12 patients. Seven of the 11 patients with hypertriglyceridemia developed abdominal pain similar to but not as severe as that experienced during prior attacks of pancreatitis. Four of the seven patients with abdominal pain developed serum amylase elevations, and, of the remaining three, one had a serum lipase elevation and one a urinary amylase elevation. Alcohol ingestion is known to increase serum triglyceride levels in many individuals. A prior study demonstrated that 41 percent of the patients presenting to our hospital with alcoholic pancreatitis had serum triglyceride elevations. The data from the present study suggest that increased serum triglycerides act as an important intermediary in the pathogenesis of
acute pancreatitis
in some alcoholic patients.
...
PMID:A pathogenesis for alcoholic pancreatitis. 114 40
In 6 of 7 patients with
acute pancreatitis
and
hyperlipemia
, inhibition of serum amylase activity was detected by dilution of the serum before assaying for amylase and by correcting for tthe dilution factor. In 4 patients the inhibition phenomenon disappeared within the first few days of hospitalization as the elevated serum triglycerides fell. However, in 2 others there was no relation between triglyceride level and amylase inhibition. Removal of the excess serum lipids by ultracentrifugation did not eliminate the inhibition of amylase activity. Inhibition of amylase activity also occurred in the urine of these patients. No amylase inhibition was demonstrable in lipemic serum from patients without pancreatitis or in pancreatitis serum to which excess lipids were added. The data suggest the presence of a circulating inhibitor of amylase, distinct from the elevated serum lipids, in the serum and urine of patients with
acute pancreatitis
associated with
hyperlipemia
. The diagnosis of
acute pancreatitis
in the patient with abdominal pain and lactescent serum can be facilitated by correcting the serum amylase activity by dilution.
...
PMID:Inhibition of serum and urine amylase activity in pancreatitis with hyperlipemia. 114 12
It is discussed the case of a patient, a 45 year old female, who suffered two episodes of
acute pancreatitis
in one year. This patient is not an alcoholic but diabetic, atherosclerotic and with type IV
hyperlipemia
. It is presented some reports of the medical literature on the matter and some possible pathogenic mechanisms to explain the pancreatitis associated to
hyperlipemia
. In this particular case the authors do not consider the
hyperlipemia
secondary to a pancreatitis but a precipitating factor.
...
PMID:[Recurrent pancreatitis and hyperlipemia. Clinical case and review of the literature]. 120 40
1
2
3
4
5
6
7
8
9
10
Next >>